Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
Archivos espanoles de urologia(2)
Actas Urologicas Espanolas(1)
BJU International(1)
European Urology Focus(1)
Área temáticas
Enfermedades(5)
Farmacología y terapéutica(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Medicina y salud(1)
Origen
scopus(5)
Biomarcadores en el manejo del cáncer de próstata. ¿Hay algo nuevo?
ReviewAbstract: INTRODUCTION: Prostate cancer (PCa) diagnosis cornerstone has been prostate-specific antigen levelsPalabras claves:BIOMARCADOR, Biomarker, CÁNCER DE PRÓSTATA, DIÁGNOSTICO, Genetic assay, prognosis, Pronostico, Prostate cancer, screening, Test genéticoAutores:Alvarez-Maestro M., Diego M. Carrión, Martinez-Piñéiro L., Rivas J.G.Fuentes:scopusDeveloping a Diagnostic Multivariable Pbkp_rediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study
ArticleAbstract: Background: Patient factors associated with urinary tract cancer can be used to risk stratify patienPalabras claves:bladder cancer, Haematuria, Prostate cancer, Renal cancer, Risk Calculator, RISK FACTORS, Urinary tract cancer, Urothelial cancerAutores:Abroaf A., Adimonye A., Ahmad A., Anbarasan T., Antón-Juanilla M., Assmus M.A., Austin T., Ayres B., Barcelos A., Bdesha A., Benitez C.A.E., Bennett A., Blick C., Boltri M., Boxall N.E., Brown C., Burnhope T., Cebola A., Challacombe B., Chaudry A., Chin Y.F., Chippagiri A., Claps F., Czech A.K., Das A., de Jalón Á.G., Desai A., Dhanasekaran A.K., Diego M. Carrión, Dowling C., Downey A.P., Drake T., Ebur A., Edison E., Figueiredo A., Gallagher K.M., Gallegos C., Galosi A.B., Gao C., Goulao B., Green J.S.A., Grigorakis A., Ho C.W.Y., Hobbs C., Jefferies M., Kasivisvanathan V., Khadhouri S., Knight A., Kondža A., La Montagna G., Lai B., Lal A.A., Lam C.M., Lebacle C., Lee T., Leminski A., Lloyd A., MacKay A., MacKenzie K.R., MacLennan G., Mainwaring A., Mannas M.P., Marcq G., Marra G., McGrath J.S., McKay A., Minervini A., Moore M., Moore S., Mount C., Mukhtar B., Nagle A., Nambiar A., Nellensteijn B., Ng C.F., Nielsen M., Nkwam N., Oo A.M.M., Rai S., Ristau B., Rivas J.G., Russell A., Schneider A., Schreiter B., Shah T.T., Sharma A., Sherwood B., Silva A., Sukhu T.A., Suliman A.M., Trombetta C., Ucar T., Uzan A., Villers A., Voulgaris A.M., Webb A., Wong A., Yıldırım A., Younis A., Zelhof B., Zimmermann E.F.Fuentes:scopusCáncer de próstata de alto riesgo. Tratamiento óptimo. Nuevas evidencias
ArticleAbstract: There are multiple definitions of high risk prostate cancer and each definition is associated with aPalabras claves:Alto riesgo, CÁNCER DE PRÓSTATA, High risk, management, New evidence, Nueva evidencia, Optimal treatment, Prostate cancer, tratamiento, Tratamiento óptimoAutores:Alvarez-Maestro M., Bazán A.A., Diego M. Carrión, Juarez Soto A., Martinez-Piñéiro L., Quesada-Olarte J.M., Rios González E., Rivas J.G.Fuentes:scopusThe IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer – a multicentre observational study
ArticleAbstract: Objective: To evaluate the contemporary prevalence of urinary tract cancer (bladder cancer, upper trPalabras claves:bladder cancer, cancer prevalence, Haematuria, HEMATURIA, Prostate cancer, Renal cancer, upper tract urothelial cancer, Urinary tract cancerAutores:Abroaf A., Adimonye A., Ahmad A., Antón-Juanilla M., Assmus M.A., Ayres B., Barcelos A., Bdesha A., Benitez C.A.E., Bennett A., Blick C., Boltri M., Boxall N.E., Brown C., Burnhope T., Cebola A., Challacombe B., Chaudry A., Chippagiri A., Chuchu N., Claps F., Clarke H., Crockett M., Czech A.K., Das A., Desai A., Dhanasekaran A.K., Diego M. Carrión, Dowling C., Downey A.P., Ebur A., Edison E., Figueiredo A., Gallagher K.M., Gallegos C., Galosi A.B., Gao C., García de Jalón Á., Gillams K., Grigorakis A., Higgs C., Ho C.W.Y., Hobbs C., Jefferies M., Kasivisvanathan V., Khadhouri S., Knight A., Kondža A., Lai B., Lal A.A., Lam C.M., Lau D.H.W., Lebacle C., Lee T., Leminski A., Lillaz B., Lloyd A., MacKay A., MacKenzie K.R., MacLennan G., Mainwaring A., Mannas M.P., Marra G., McGrath J.S., McKay A., Minervini A., Moore S., Mount C., Mukhtar B., Nagle A., Nambiar A., Nellensteijn B., Ng C.F., Nielsen M., Nkwam N., Olivier J., Oo A.M.M., O’Rourke J., Ristau B., Rivas J.G., Russell A., Schneider A., Schreiter B., Shah T.T., Sharma A., Sherwood B., Silva A., Suliman A.M., Takwoingi Y., Tanasescu G., Trombetta C., Ucar T., Uzan A., Villers A., Voulgaris A.M., Webb A., Wong A., Yıldırım A., Younis A., Zelhof B., Zimmermann E.F.Fuentes:scopusThe role of multiparametric magnetic resonance imaging in the selection and follow-up of patients undergoing active surveillance for prostate cancer. An European Section of Uro-Technology (ESUT) review
ReviewAbstract: Introduction: In recent years, active surveillance (AS) has gained popularity as a safe and reasonabPalabras claves:Active surveillance, Multiparametric magnetic resonance imaging, Prostate cancerAutores:Alvarez-Maestro M., Barret E., Chandrasekar T., Diego M. Carrión, Enikeev D., Martinez-Piñéiro L., Rivas J.G.Fuentes:scopus